US Stock MarketDetailed Quotes

EFTR eFFECTOR Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Nov 15 16:00 ET
940.88Market Cap0.00P/E (TTM)

eFFECTOR Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.70%-7.28M
-14.10%-29.55M
17.91%-5.57M
5.24%-7.76M
-93.60%-8.59M
-17.55%-7.64M
-4.06%-25.9M
-35.38%-6.78M
9.74%-8.18M
23.69%-4.44M
Net income from continuing operations
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Operating gains losses
----
99.53%-3K
----
----
----
----
-18.18%-637K
--0
86.51%-39K
-666.67%-153K
Depreciation and amortization
0.00%28K
109.43%111K
11.11%30K
44.44%26K
800.00%27K
460.00%28K
120.83%53K
440.00%27K
200.00%18K
-50.00%3K
Other non cash items
8.79%99K
103.26%346K
13.16%86K
1,050.00%76K
108.02%93K
100.95%91K
78.14%-10.62M
100.24%76K
99.95%-8K
-1,373.63%-1.16M
Change In working capital
-60.41%479K
-37.06%1.69M
115.63%2.43M
-269.50%-521K
-157.93%-1.43M
255.13%1.21M
1,224.79%2.68M
-39.27%1.13M
94.01%-141K
547.02%2.47M
-Change in prepaid assets
248.33%267K
-62.73%587K
-78.51%185K
72.38%-364K
-32.19%946K
-128.26%-180K
224.02%1.58M
-12.05%861K
28.76%-1.32M
249.84%1.4M
-Change in payables and accrued expense
-88.13%159K
0.11%907K
926.64%2.2M
-118.03%-203K
-335.53%-2.43M
191.46%1.34M
-53.44%906K
-74.12%214K
149.12%1.13M
169.63%1.03M
-Change in other current assets
10.42%53K
0.00%192K
0.00%48K
0.00%48K
0.00%48K
0.00%48K
121.26%192K
2.13%48K
105.05%48K
--48K
-Change in other working capital
----
-125.00%-1K
-166.67%-2K
-166.67%-2K
--0
400.00%3K
136.36%4K
200.00%3K
175.00%3K
75.00%-1K
Cash from discontinued investing activities
Operating cash flow
4.70%-7.28M
-14.10%-29.55M
17.91%-5.57M
5.24%-7.76M
-93.60%-8.59M
-17.55%-7.64M
-4.06%-25.9M
-35.38%-6.78M
9.74%-8.18M
23.69%-4.44M
Investing cash flow
Cash flow from continuing investing activities
-170.02%-6.32M
181.10%14.48M
146.99%8.95M
-152.86%-1.92M
-149.67%-1.57M
131.93%9.03M
-3,261.06%-17.86M
10,161.11%3.62M
60,483.33%3.62M
3.17M
Net PPE purchase and sale
--0
49.48%-97K
-315.38%-54K
95.56%-2K
63.64%-28K
77.19%-13K
-133.98%-192K
63.89%-13K
-650.00%-45K
---77K
Net investment purchase and sale
-169.92%-6.32M
182.53%14.58M
147.59%9M
-152.15%-1.91M
-147.63%-1.55M
132.04%9.04M
---17.67M
--3.64M
--3.67M
--3.25M
Cash from discontinued investing activities
Investing cash flow
-170.02%-6.32M
181.10%14.48M
146.99%8.95M
-152.86%-1.92M
-149.67%-1.57M
131.93%9.03M
-3,261.06%-17.86M
10,161.11%3.62M
60,483.33%3.62M
--3.17M
Financing cash flow
Cash flow from continuing financing activities
6,613.21%14.23M
667.92%21.23M
16,610.81%6.11M
208.11%342K
34,790.48%14.57M
-92.24%212K
-95.30%2.77M
-68.18%-37K
-99.79%111K
46.15%-42K
Net issuance payments of debt
---556K
----
----
----
----
--0
----
----
----
----
Net common stock issuance
6,875.00%14.79M
656.59%21.18M
16,610.81%6.11M
191.89%324K
34,700.00%14.53M
-92.34%212K
--2.8M
---37K
793.75%111K
-362.50%-42K
Proceeds from stock option exercised by employees
--1K
1,766.67%56K
--0
--18K
--38K
--0
-94.64%3K
--0
--0
--0
Net other financing activities
----
----
----
----
----
----
-100.07%-37K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
6,613.21%14.23M
667.92%21.23M
16,610.81%6.11M
208.11%342K
34,790.48%14.57M
-92.24%212K
-95.30%2.77M
-68.18%-37K
-99.79%111K
46.15%-42K
Net cash flow
Beginning cash position
70.82%14.88M
-82.48%8.71M
-54.75%5.39M
-10.02%14.71M
-41.63%10.31M
-82.48%8.71M
226.64%49.7M
-78.27%11.9M
50.30%16.35M
5.31%17.66M
Current changes in cash
-60.49%633K
115.04%6.17M
397.00%9.49M
-109.62%-9.33M
435.93%4.4M
105.00%1.6M
-218.87%-40.99M
36.93%-3.2M
-110.14%-4.45M
77.76%-1.31M
End cash Position
50.42%15.51M
70.82%14.88M
70.82%14.88M
-54.75%5.39M
-10.02%14.71M
-41.63%10.31M
-82.48%8.71M
-82.48%8.71M
-78.27%11.9M
50.30%16.35M
Free cash flow
4.86%-7.28M
-13.63%-29.65M
17.27%-5.62M
5.74%-7.76M
-90.92%-8.62M
-16.72%-7.65M
-4.66%-26.09M
-34.67%-6.79M
9.30%-8.23M
22.37%-4.52M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.70%-7.28M-14.10%-29.55M17.91%-5.57M5.24%-7.76M-93.60%-8.59M-17.55%-7.64M-4.06%-25.9M-35.38%-6.78M9.74%-8.18M23.69%-4.44M
Net income from continuing operations 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Operating gains losses ----99.53%-3K-----------------18.18%-637K--086.51%-39K-666.67%-153K
Depreciation and amortization 0.00%28K109.43%111K11.11%30K44.44%26K800.00%27K460.00%28K120.83%53K440.00%27K200.00%18K-50.00%3K
Other non cash items 8.79%99K103.26%346K13.16%86K1,050.00%76K108.02%93K100.95%91K78.14%-10.62M100.24%76K99.95%-8K-1,373.63%-1.16M
Change In working capital -60.41%479K-37.06%1.69M115.63%2.43M-269.50%-521K-157.93%-1.43M255.13%1.21M1,224.79%2.68M-39.27%1.13M94.01%-141K547.02%2.47M
-Change in prepaid assets 248.33%267K-62.73%587K-78.51%185K72.38%-364K-32.19%946K-128.26%-180K224.02%1.58M-12.05%861K28.76%-1.32M249.84%1.4M
-Change in payables and accrued expense -88.13%159K0.11%907K926.64%2.2M-118.03%-203K-335.53%-2.43M191.46%1.34M-53.44%906K-74.12%214K149.12%1.13M169.63%1.03M
-Change in other current assets 10.42%53K0.00%192K0.00%48K0.00%48K0.00%48K0.00%48K121.26%192K2.13%48K105.05%48K--48K
-Change in other working capital -----125.00%-1K-166.67%-2K-166.67%-2K--0400.00%3K136.36%4K200.00%3K175.00%3K75.00%-1K
Cash from discontinued investing activities
Operating cash flow 4.70%-7.28M-14.10%-29.55M17.91%-5.57M5.24%-7.76M-93.60%-8.59M-17.55%-7.64M-4.06%-25.9M-35.38%-6.78M9.74%-8.18M23.69%-4.44M
Investing cash flow
Cash flow from continuing investing activities -170.02%-6.32M181.10%14.48M146.99%8.95M-152.86%-1.92M-149.67%-1.57M131.93%9.03M-3,261.06%-17.86M10,161.11%3.62M60,483.33%3.62M3.17M
Net PPE purchase and sale --049.48%-97K-315.38%-54K95.56%-2K63.64%-28K77.19%-13K-133.98%-192K63.89%-13K-650.00%-45K---77K
Net investment purchase and sale -169.92%-6.32M182.53%14.58M147.59%9M-152.15%-1.91M-147.63%-1.55M132.04%9.04M---17.67M--3.64M--3.67M--3.25M
Cash from discontinued investing activities
Investing cash flow -170.02%-6.32M181.10%14.48M146.99%8.95M-152.86%-1.92M-149.67%-1.57M131.93%9.03M-3,261.06%-17.86M10,161.11%3.62M60,483.33%3.62M--3.17M
Financing cash flow
Cash flow from continuing financing activities 6,613.21%14.23M667.92%21.23M16,610.81%6.11M208.11%342K34,790.48%14.57M-92.24%212K-95.30%2.77M-68.18%-37K-99.79%111K46.15%-42K
Net issuance payments of debt ---556K------------------0----------------
Net common stock issuance 6,875.00%14.79M656.59%21.18M16,610.81%6.11M191.89%324K34,700.00%14.53M-92.34%212K--2.8M---37K793.75%111K-362.50%-42K
Proceeds from stock option exercised by employees --1K1,766.67%56K--0--18K--38K--0-94.64%3K--0--0--0
Net other financing activities -------------------------100.07%-37K--0--0--0
Cash from discontinued financing activities
Financing cash flow 6,613.21%14.23M667.92%21.23M16,610.81%6.11M208.11%342K34,790.48%14.57M-92.24%212K-95.30%2.77M-68.18%-37K-99.79%111K46.15%-42K
Net cash flow
Beginning cash position 70.82%14.88M-82.48%8.71M-54.75%5.39M-10.02%14.71M-41.63%10.31M-82.48%8.71M226.64%49.7M-78.27%11.9M50.30%16.35M5.31%17.66M
Current changes in cash -60.49%633K115.04%6.17M397.00%9.49M-109.62%-9.33M435.93%4.4M105.00%1.6M-218.87%-40.99M36.93%-3.2M-110.14%-4.45M77.76%-1.31M
End cash Position 50.42%15.51M70.82%14.88M70.82%14.88M-54.75%5.39M-10.02%14.71M-41.63%10.31M-82.48%8.71M-82.48%8.71M-78.27%11.9M50.30%16.35M
Free cash flow 4.86%-7.28M-13.63%-29.65M17.27%-5.62M5.74%-7.76M-90.92%-8.62M-16.72%-7.65M-4.66%-26.09M-34.67%-6.79M9.30%-8.23M22.37%-4.52M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data